Effect of Famotidine on COVID-19: Killing Virus or Opposing ARDS?
Abstract Since the first detection of SARS-CoV-2 in China, COVID-19 (Corona Virus Disease 2019) has taken the lives of more than six million people. Although some antivirals seem proper for treatment, the investigation of finding the best therapeutic approach for COVID-19 is still continuing. Some o...
Main Authors: | Mahnaz Sadat Hosseini, Effat Davoudi-Monfared, Farhad Najmeddin, Mojtaba Mojtahedzadeh |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2023-04-01
|
Series: | Pulmonary Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s41030-023-00220-4 |
Similar Items
-
Preparation and evaluation of famotidine nanosuspension
by: Marwa M. Malik, et al.
Published: (2018-12-01) -
The Efficacy of Famotidine in Improvement of Outcomes in Hospitalized COVID-19 Patients: A Phase III Randomized Clinical Trial
by: Hamid Reza Samimagham, et al.
Published: (2022-05-01) -
Synthesis, Crystal Structure, and Solubility Analysis of a Famotidine Cocrystal
by: Yan Zhang, et al.
Published: (2019-07-01) -
A method for improving the properties of famotidine
by: Yongfeng Zhao, et al.
Published: (2023-06-01) -
Development and evaluation of novel-trans-buccoadhesive films of famotidine
by: M Alagusundaram, et al.
Published: (2011-01-01)